WhichRecall
Class IIReported 2025-09-17

4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)

Recalled by Exela Pharma Sciences LLC

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.

Advertisement
Recall Number
D-0620-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-07-30
Reported
2025-09-17
Distribution
Nationwide in the USA
Code Info
Lot # 10004077, Exp. 02/28/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement